Cullen/Frost Bankers’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-338
Closed -$17.4K – 1453
2026
Q1
$17.4K Buy
+338
New +$23.7K ﹤0.01% 1015
2025
Q3
– Sell
-102
Closed -$13.2K – 1389
2025
Q2
$13.2K Buy
+102
New +$14.8K ﹤0.01% 990
2024
Q3
– Sell
-31
Closed -$4.15K – 1298
2024
Q2
$4.15K Buy
+31
New +$5.87K ﹤0.01% 983

Other funds holding INSP

Cullen/Frost Bankers's INSP Position: Q2 2026 in Review

Cullen/Frost Bankers sold out of Inspire Medical Systems (INSP) in Q2 2026, closing a stake of 338 shares — an estimated $17.4K sold.

Cullen/Frost Bankers first reported a position in INSP in Q2 2024 and held it in 3 quarters. The position peaked at $17.4K in Q1 2026. 275 funds tracked by Wall St. Rank hold INSP as of Q2 2026.

  • Cullen/Frost Bankers reported no remaining Inspire Medical Systems position as of Q2 2026 after selling out during the quarter.
  • Cullen/Frost Bankers sold 338 Inspire Medical Systems shares in Q2 2026, an estimated $17.4K.
  • Cullen/Frost Bankers first reported a position in Inspire Medical Systems in Q2 2024 and held it in 3 quarters.
  • Cullen/Frost Bankers's Inspire Medical Systems position peaked at $17.4K in Q1 2026.
  • 275 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.

Based on Cullen/Frost Bankers's 13F filing for Q2 2026, filed 27 Jul 2026.